Rigel Pharmaceuticals, Inc.
RIGL
$42.58
$1.794.39%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 95.33M | 146.68M | 154.96M | 137.14M | 108.38M |
| Total Receivables | 56.04M | 49.95M | 51.76M | 45.93M | 39.91M |
| Inventory | 24.15M | 25.06M | 23.36M | 20.61M | 15.83M |
| Prepaid Expenses | 4.99M | 5.20M | 4.89M | 5.39M | 5.84M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 5.03M | 7.14M | 5.21M | 5.86M | 5.44M |
| Total Current Assets | 185.53M | 234.03M | 240.17M | 214.93M | 175.39M |
|
|
|||||
| Total Current Assets | 185.53M | 234.03M | 240.17M | 214.93M | 175.39M |
| Net Property, Plant & Equipment | 647.00K | 785.00K | 950.00K | 1.10M | 1.24M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 93.88M | 24.16M | 24.75M | 25.34M | 25.92M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 241.01M | 245.64M | 247.73M | 1.17M | 4.18M |
| Total Assets | 521.07M | 504.61M | 513.59M | 242.53M | 206.74M |
|
|
|||||
| Total Accounts Payable | 4.01M | 4.49M | 7.19M | 3.85M | 7.29M |
| Total Accrued Expenses | 46.31M | 44.43M | 50.46M | 48.98M | 45.18M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 39.89M | 30.50M | 30.43M | 30.36M | 22.88M |
| Total Finance Division Other Current Liabilities | 5.38M | 10.08M | 11.16M | 11.22M | 11.28M |
| Total Other Current Liabilities | 5.38M | 10.08M | 11.16M | 11.22M | 11.28M |
| Total Current Liabilities | 95.59M | 89.49M | 99.24M | 94.40M | 86.64M |
|
|
|||||
| Total Current Liabilities | 95.59M | 89.49M | 99.24M | 94.40M | 86.64M |
| Long-Term Debt | -- | 14.99M | 22.48M | 29.97M | 37.45M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 58.00K | 228.00K | 395.00K | 556.00K | 714.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 95.64M | 104.71M | 122.11M | 124.93M | 124.80M |
|
|
|||||
| Common Stock & APIC | 1.42B | 1.41B | 1.41B | 1.41B | 1.40B |
| Retained Earnings | -997.10M | -1.01B | -1.02B | -1.29B | -1.32B |
| Treasury Stock & Other | -148.00K | -128.00K | 181.00K | 96.00K | 6.00K |
| Total Common Equity | 425.42M | 399.90M | 391.48M | 117.61M | 81.93M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 425.42M | 399.90M | 391.48M | 117.61M | 81.93M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 425.42M | 399.90M | 391.48M | 117.61M | 81.93M |
|
|
|||||